MOCHIDA PHARMACEUTICAL CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 74181
 
  
 
C07D HETEROCYCLIC COMPOUNDS 23139
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 13193
 
  
 
C07K PEPTIDES 9127
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 788
 
  
 
A23L FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT 460
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0015,038 OMEGA-3 FATTY ACID SELF-EMULSIFYING COMPOSITIONJan 20, 16Jan 18, 18[A61K]
2017/0368,184 SELF-EMULSIFYING COMPOSITION OF OMEGA-3 FATTY ACIDJan 21, 15Dec 28, 17[A61K]
2017/0348,268 SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACIDAug 23, 17Dec 07, 17[A61K, A23L]
2017/0348,273 SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACIDJan 21, 16Dec 07, 17[A61K, A23L]
2017/0304,249 EMULSION AND EMULSION PRECONCENTRATE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND USES THEREOF ARE DISCLOSEDJun 23, 17Oct 26, 17[A61K, A23L, A23D]
2017/0273,928 COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENTJun 12, 17Sep 28, 17[A61K]
2017/0273,929 CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEINJun 09, 17Sep 28, 17[A61K, G01N]
2017/0252,315 COMPOSITION CONTAINING EICOSAPENTAENOIC ACID ALKYL ESTER, AND METHOD FOR PRODUCING SAMESep 17, 15Sep 07, 17[A61K]
2017/0079,946 COMPOSITION FOR REDUCING NEW-ONSET DIABETESNov 30, 16Mar 23, 17[A61K]
2016/0377,615 METHOD FOR EVALUATION OF FUNCTION OF PHAGOCYTESep 07, 16Dec 29, 16[G01N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918953 Composition containing eicosapentaenoic acid alkyl ester, and method for producing sameSep 17, 15Mar 20, 18[C11B, A61K, C07C, C11C]
9914727 Factor IXa inhibitorsDec 16, 13Mar 13, 18[C07D]
9902723 Pyrazole derivative manufacturing methodJul 29, 15Feb 27, 18[A61K, C07D]
9889108 Compositions and methods for treating non-alcoholic steatohepatitisMar 14, 14Feb 13, 18[A61K]
9879009 Pyrazole derivative manufacturing methodJul 29, 15Jan 30, 18[A61K, C07D]
9821027 Method for regenerating cartilage comprising applying a monovalent metal salt of alginic acid and SDF-1Nov 18, 15Nov 21, 17[A61K, A61L]
9808445 Factor IXa inhibitorsApr 10, 15Nov 07, 17[A61K, C07D]
9801843 Self-emulsifying composition of ω3 fatty acidJul 17, 14Oct 31, 17[A61K, A23L, A61Q]
9789068 Easily dosable solid preparationJan 31, 17Oct 17, 17[A61K]
9777000 Pyrazole derivativeAug 11, 16Oct 03, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0115,542 BIOMARKER OF Nrf2 ACTIVATIONAbandonedMay 28, 14Apr 28, 16[C12Q, G01N]
2016/0089,355 COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENTAbandonedDec 09, 15Mar 31, 16[A61K]
2016/0045,469 COMPOSITION AND/OR METHOD FOR PREVENTING ONSET AND/OR RECURRENCE OF CARDIOVASCULAR EVENTSAbandonedOct 29, 15Feb 18, 16[A61K]
2015/0266,839 CYCLIC AMIDE DERIVATIVEAbandonedJun 03, 15Sep 24, 15[A61K, C07D]
2015/0225,392 CYCLIC AMIDE DERIVATIVEAbandonedApr 21, 15Aug 13, 15[A61K, C07D]
2014/0364,335 METHOD FOR SCREENING FOR NRF1 REGULATORAbandonedJan 23, 13Dec 11, 14[G01N]
2014/0213,524 COMPOSITION FOR REGENERATION OF CARTILAGEAbandonedAug 22, 12Jul 31, 14[A61K]
2014/0050,727 ANTI-CD14 ANTIBODY FUSION PROTEINAbandonedAug 21, 13Feb 20, 14[C07K]
2014/0039,053 THERAPEUTIC AGENT FOR DIASTOLIC CONGESTIVE HEART FAILUREAbandonedFeb 06, 12Feb 06, 14[A61K]
8629102 3-hydroxyisothiazole 1-oxide derivativesExpiredMar 15, 13Jan 14, 14[A61K, A01N, A61P, C07K]
2013/0303,614 AGENT FOR INHIBITING ELEVATION IN BLOOD GLUCOSE LEVELAbandonedNov 08, 11Nov 14, 13[A61K]
2013/0280,252 METHOD FOR SELECTING PATIENT TO BE GIVEN DRUG FOR TREATING SEPTICEMIAAbandonedJan 05, 12Oct 24, 13[A61K]
8541565 Polynucleotide encoding anti-CD14 antibody fusion proteinExpiredJul 12, 12Sep 24, 13[C07H, A61K, C12P, C12N]
8524870 Anti-platelet membrane glycoprotein VI monoclonal antibodyExpiredDec 20, 12Sep 03, 13[C12P]
2013/0217,050 METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE USING-SOLUBLE GPVIAbandonedSep 06, 11Aug 22, 13[G01N]
8461141 Preventive or therapeutic drug for Alzheimer-type dementiaExpiredJul 09, 10Jun 11, 13[A61K, A01N]
8455500 3-hydroxy-5-arylisoxazole derivativeExpiredOct 29, 10Jun 04, 13[A61K, C07D]
8389692 Anti-platelet membrane glycoprotein VI monoclonal antibodyExpiredApr 27, 11Mar 05, 13[C12P]
8383839 Heterocyclidene acetamide derivativeExpiredJan 18, 11Feb 26, 13[C07D]
2013/0029,978 NOVEL ARYL UREA DERIVATIVEAbandonedDec 24, 10Jan 31, 13[A61K, C07D, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.